CONTEXT THERAPEUTICS INC (CNTX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CNTX - US21077P1084 - Common Stock

2.36 USD

+0.17 (+7.76%)

Last: 1/28/2026, 2:08:15 PM

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CNTX. CNTX was compared to 190 industry peers in the Pharmaceuticals industry. While CNTX has a great health rating, there are worries on its profitability. CNTX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CNTX has reported negative net income.
CNTX had a negative operating cash flow in the past year.
CNTX had negative earnings in 4 of the past 5 years.
In the past 5 years CNTX always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of CNTX (-33.47%) is comparable to the rest of the industry.
CNTX has a Return On Equity (-36.22%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-33.47%
ROE	-36.22%
ROIC	N/A

ROA(3y)-72.21%

ROA(5y)235.15%

ROE(3y)-90.37%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CNTX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, CNTX has more shares outstanding
Compared to 5 years ago, CNTX has more shares outstanding
CNTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 17.66 indicates that CNTX is not in any danger for bankruptcy at the moment.
CNTX's Altman-Z score of 17.66 is amongst the best of the industry. CNTX outperforms 85.26% of its industry peers.
CNTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	17.66

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

CNTX has a Current Ratio of 13.08. This indicates that CNTX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CNTX (13.08) is better than 81.58% of its industry peers.
A Quick Ratio of 13.08 indicates that CNTX has no problem at all paying its short term obligations.
The Quick ratio of CNTX (13.08) is better than 81.58% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	13.08
Quick Ratio	13.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CNTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.23%, which is quite impressive.

EPS 1Y (TTM)69.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%54.55%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CNTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.39% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y32.81%

EPS Next 2Y9.99%

EPS Next 3Y7.15%

EPS Next 5Y11.39%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNTX. In the last year negative earnings were reported.
Also next year CNTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.